본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

초록보기

Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.

Materials and Methods The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)–free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).

Results The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy–free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.

Conclusion Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes.

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
(Editorial) The rise of particle beam therapy : are we ready for the potential game-changer? Eui Kyu Chie, Yong Chan Ahn p. 609-610

Physical and biological characteristics of particle therapy for oncologists Hwa Kyung Byun, Min Cheol Han, Kyungmi Yang, Jin Sung Kim, Gyu Sang Yoo, Woong Sub Koom, Yong Bae Kim p. 611-620

Who will benefit from charged-particle therapy? Kyung Su Kim, Hong-Gyun Wu p. 621-634

Technological advances in charged-particle therapy Jong Min Park, Jung-in Kim, Hong-Gyun Wu p. 635-640

Depression, rather than cancer-related fatigue or insomnia, decreased the quality of life of cancer patients Sungook Yeo, Joohee Lee, Kyumin Kim, Hwa Jung Kim, Seockhoon Chung p. 641-649

Genetic susceptibility of ACE2 and TMPRSS2 in six common cancers and possible impacts on COVID-19 Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran p. 650-656

Development and validation of web-based nomograms to precisely predict survival outcomes of non-metastatic nasopharyngeal carcinoma in an endemic area Ji-Jin Yao, Li Lin, Tian-Sheng Gao, Wang-Jian Zhang, Wayne R. Lawrence, Jun Ma, Ying Sun p. 657-670

Outcomes and biomarkers of immune checkpoint inhibitor therapy in patients with refractory head and neck squamous cell carcinoma : KCSG HN18-12 Yun-Gyoo Lee, Hyun Chang, Bhumsuk Keam, Sang Hoon Chun, Jihyun Park, Keon Uk Park, Seong Hoon Shin, Ho Jung An, Kyoung Eun Lee, Keun-Wook Lee, Hye Ryun Kim, Sung-Bae Kim, Myung-Ju Ahn, In Gyu Hwang p. 671-677

Risk of coronavirus disease 2019 occurrence, severe presentation, and mortality in patients with lung cancer Bumhee Yang, Hayoung Choi, Sun-Kyung Lee, Sung Jun Chung, Yoomi Yeo, Yoon Mi Shin, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Yun Su Sim, Ho Joo Yoon, Jang Won Sohn, Hyun Lee, Sang-Heon Kim p. 678-684

Synergistic tumoricidal effects of alpha-lipoic acid and radiotherapy on human breast cancer cells via HMGB1 Hoon Sik Choi, Jin Hyun Kim, Si Jung Jang, Jeong Won Yun, Ki Mun Kang, Hojin Jeong, In Bong Ha, Bae Kwon Jeong p. 685-694

Implications of tamoxifen resistance in palbociclib efficacy for patients with hormone receptor-positive, HER2-negative metastatic breast cancer : subgroup analyses of KCSG-BR15-10 (YoungPEARL) Jiyun Lee, Seock-Ah Im, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Hee Kyung Ahn, Yeon Hee Park p. 695-702

Optimal maintenance strategy for first-line oxaliplatin-containing therapy with or without bevacizumab in patients with metastatic colorectal cancer : a meta-analysis Toshikazu Moriwaki, Masahiko Gosho, Akinori Sugaya, Takeshi Yamada, Yoshiyuki Yamamoto, Ichinosuke Hyodo p. 703-713

Risk of death in colorectal cancer patients with multi-morbidities of metabolic syndrome : a retrospective multicohort analysis Qingting Feng, Lingkai Xu, Lin Li, Junlan Qiu, Ziwei Huang, Yiqing Jiang, Tao Wen, Shun Lu, Fang Meng, Xiaochen Shu p. 714-723

Polymorphisms in TYMS for prediction of capecitabine-induced hand-foot syndrome in Chinese patients with colorectal cancer Si-Qi Dong, Tong-Min Wang, Jiang-Bo Zhang, Yong-Qiao He, Wen-Qiong Xue, Zi-Yi Wu, Da-Wei Yang, Lian-Jing Cao, Jing-Wen Huang, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Wei-Hua Jia p. 724-732

(The) establishment of a fast and safe orthotopic colon cancer model using a tissue adhesive technique Hong-Tao Hu, Zhe Wang, Myung Ji Kim, Lu-Shang Jiang, Shi-Jun Xu, Jaeyun Jung, Eunji Lee, Jung-Hoon Park, Nader Bakheet, Sung Hwan Yoon, Kun Yung Kim, Ho-Young Song, Suhwan Chang p. 733-743

Population attributable fraction of helicobacter pylori infection-related gastric cancer in Korea : a meta-analysis Yoon Park, Moran Ki p. 744-753

Association between ALDH2 and ADH1B polymorphisms and the risk for colorectal cancer in Koreans Chang Kyun Choi, Min-Ho Shin, Sang-Hee Cho, Hye-Yeon Kim, Wei Zheng, Jirong Long, Sun-Seog Kweon p. 754-762

Development and validation of a symptom-focused quality of life questionnaire(KOQUSS-40)for gastric cancer patients after gastrectomy Bang Wool Eom, Joongyub Lee, In Seob Lee, Young-Gil Son, Keun Won Ryu, Sung Geun Kim, Hyoung-Il Kim, Young-Woo Kim, Seong-Ho Kong, Oh Kyoung Kwon ... [et al.] p. 763-772

LASSO-based machine learning algorithm for prediction of lymph node metastasis in T1 colorectal cancer Jeonghyun Kang, Yoon Jung Choi, Im-kyung Kim, Hye Sun Lee, Hogeun Kim, Seung Hyuk Baik, Nam Kyu Kim, Kang Young Lee p. 773-783

Double tract reconstruction reduces reflux esophagitis and improves quality of life after radical proximal gastrectomy for patients with upper gastric or esophagogastric adenocarcinoma Xin Ji, Chenggen Jin, Ke Ji, Ji Zhang, Xiaojiang Wu, Ziyu Jia, Zhaode Bu, Jiafu Ji p. 784-794

Effects of complete bladder cuff removal on oncological outcomes following radical nephroureterectomy for upper tract urothelial carcinoma Hyunsoo Ryoo, Jungyu Kim, Taejin Kim, Minyong Kang, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Hyun Hwan Sung p. 795-802

Early metabolic response assessed using 18F-FDG-PET/CT for image-guided intracavitary brachytherapy can better predict treatment outcomes in patients with cervical cancer Nalee Kim, Won Park, Won Kyung Cho, Duk-Soo Bae, Byoung-Gie Kim, Jeong-Won Lee, Tae-Joong Kim, Chel Hun Choi, Yoo-Young Lee, Young Seok Cho p. 803-812

Cervical cancer in women with normal papanicolaou tests : a Korean nationwide cohort study Miseon Kim, Hyeongsu Kim, Dong Hoon Suh, Yong Beom Kim p. 813-818

Enhanced efficacy of combined therapy with checkpoint kinase 1 inhibitor and rucaparib via regulation of Rad51 expression in BRCA wild-type epithelial ovarian cancer cells Hye-yon Cho, Yong-Beom Kim, Wook-ha Park, Jae Hong No p. 819-828

Performance and diagnostic accuracy of human papillomavirus testing on self-collected urine and vaginal samples in a referral population Hyun-Woong Cho, Jin Hwa Hong, Kyung Jin Min, Yung-Taek Ouh, Seok Ju Seong, Jun Hye Moon, Seong Hwan Cho, Jae Kwan Lee p. 829-836

Baseline total metabolic tumor volume and total lesion glycolysis measured on 18F-FDG PET-CT predict outcomes in T-cell lymphoblastic lymphoma Xiaoyan Feng, Xin Wen, Ling Li, Zhenchang Sun, Xin Li, Lei Zhang, Jingjing Wu, Xiaorui Fu, Xinhua Wang, Hui Yu, Xinran Ma, Xudong Zhang, Xinli Xie, Xingmin Han, Mingzhi Zhang p. 837-846

Prognostic stratification of patients with Burkitt lymphoma using serum β2-microglobulin levels Hyung-Don Kim, Hyungwoo Cho, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Chan-Sik Park, Jooryung Huh, Jin Sook Ryu, Sang-Wook Lee, Dok-Hyun Yoon, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim, Cheolwon Suh p. 847-856

Association among body mass index, genetic variants of FTO, and thyroid cancer risk : a hospital-based case-control study of the cancer screenee cohort in Korea Tung Hoang, Dayoung Song, Jeonghee Lee, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim p. 857-873

Clinical experience of male primary choriocarcinoma at the Samsung Medical Center Young Sok Ji, Se Hoon Park p. 874-880

Safety, efficacy, and patient satisfaction with initial peripherally inserted central catheters compared with usual intravenous access in terminally ill cancer patients : a randomized phase Ⅱ study Eun Ju Park, Kwonoh Park, Jae-Joon Kim, Sang-Bo Oh, Ki Sun Jung, So Yeon Oh, Yun Jeong Hong, Jin Hyeok Kim, Joo Yeon Jang, Ung-Bae Jeon p. 881-888

Identification of a novel CSNK2A1-PDGFRB fusion gene in a patient with myeloid neoplasm with eosinophilia Xiaoyu Xu, Qiongyu Lu, Zheng Wang, Ping Cai, Zhao Zeng, Ling Zhang, Man Wang, Liang Ma, Changgeng Ruan, Suning Chen p. 889-892

참고문헌 (30건) : 자료제공( 네이버학술정보 )

참고문헌 목록에 대한 테이블로 번호, 참고문헌, 국회도서관 소장유무로 구성되어 있습니다.
번호 참고문헌 국회도서관 소장유무
1 Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P, et al. Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature. Urol Oncol. 2014;32:54. 미소장
2 Gupta R, Paner GP, Amin MB. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol. 2008;15:127-39. 미소장
3 Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164:1523-5. 미소장
4 Allard CB, Alamri A, Dason S, Farrokhyar F, Matsumoto ED, Kapoor A. The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma. World J Urol. 2013;31:175-81. 미소장
5 Lee SM, McKay A, Grimes N, Umez-Eronini N, Aboumarzouk OM. Distal ureter management during nephroureterectomy: evidence from a systematic review and cumulative analysis. J Endourol. 2019;33:263-73. 미소장
6 Azemar MD, Comperat E, Richard F, Cussenot O, Roupret M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011;29:130-6. 미소장
7 Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2014;65:210-7. 미소장
8 Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584-94. 미소장
9 Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester R, Burger M, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013;63:1059-71. 미소장
10 Phe V, Cussenot O, Bitker MO, Roupret M. Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy? BJU Int. 2011;108:130-8. 미소장
11 Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73:111-22. 미소장
12 Li WM, Shen JT, Li CC, Ke HL, Wei YC, Wu WJ, et al. Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol. 2010;57:963-9. 미소장
13 Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budaus L, et al. Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur Urol. 2010;57:956-62. 미소장
14 Walton TJ, Sherwood BT, Parkinson RJ, Obakponovwe O, Thomas SA, Taylor MC, et al. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma. J Urol. 2009;181:532-9. 미소장
15 Romero FR, Schaeffer EM, Muntener M, Trock B, Kavoussi LR, Jarrett TW. Oncologic outcomes of extravesical stapling of distal ureter in laparoscopic nephroureterectomy. J Endourol. 2007;21:1025-7. 미소장
16 Ko R, Chew BH, Hickling DR, Razvi H, Luke PP, Chin JL, et al. Transitional-cell carcinoma recurrence rate after nephroureterectomy in patients who undergo open excision of bladder cuff v transurethral incision of the ureteral orifice. J Endourol. 2007;21:730-4. 미소장
17 Matin SF, Gill IS. Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J Urol. 2005;173:395-400. 미소장
18 Saika T, Nishiguchi J, Tsushima T, Nasu Y, Nagai A, Miyaji Y, et al. Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis. Urology. 2004;63:848-52. 미소장
19 Salvador-Bayarri J, Rodriguez-Villamil L, Imperatore V, Palou Redorta J, Villavicencio-Mavrich H, Vicente-Rodriguez J. Bladder neoplasms after nephroureterectomy: does the surgery of the lower ureter, transurethral resection or open surgery, influence the evolution? Eur Urol. 2002;41:30-3. 미소장
20 Lai S, Guo R, Seery S, Wu P, Liu J, Zhang Y, et al. Assessing the impact of different distal ureter management techniques during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma on oncological outcomes: a systematic review and meta-analysis. Int J Surg. 2020;75:165-73. 미소장
21 Kapoor A, Dason S, Allard CB, Shayegan B, Lacombe L, Rendon R, et al. The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence. Can Urol Assoc J. 2014;8:E845-52. 미소장
22 McCarron JP, Mills C, Vaughn ED Jr. Tumors of the renal pelvis and ureter: current concepts and management. Semin Urol. 1983;1:75-81. 미소장
23 Kakizoe T, Fujita J, Murase T, Matsumoto K, Kishi K. Transitional cell carcinoma of the bladder in patients with renal pelvic and ureteral cancer. J Urol. 1980;124:17-9. 미소장
24 Babaian RJ, Johnson DE. Primary carcinoma of the ureter. J Urol. 1980;123:357-9. 미소장
25 Bloom NA, Vidone RA, Lytton B. Primary carcinoma of the ureter: a report of 102 new cases. J Urol. 1970;103:590-8. 미소장
26 Strong DW, Pearse HD. Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract. Cancer. 1976;38:2173-83. 미소장
27 Strong DW, Pearse HD, Tank ES Jr, Hodges CV. The ureteral stump after nephroureterectomy. J Urol. 1976;115:654-5. 미소장
28 Sung HH, Jeon HG, Han DH, Jeong BC, Seo SI, Lee HM, et al. Diagnostic ureterorenoscopy is associated with increased intravesical recurrence following radical nephroureterectomy in upper tract urothelial carcinoma. PLoS One. 2015;10:e0139976. 미소장
29 Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224-33. 미소장
30 Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Soulieres D, et al. Nephroureterectomy with or without bladder cuff excision for localized urothelial carcinoma of the renal pelvis. Eur Urol Focus. 2020;6:298-304. 미소장